Skip to content
About
About
Mission & Approach
Leadership
Board
Manufacturing Solutions
Manufacturing Solutions
AAV
Plasmid DNA
Technology
Pipeline & Science
Pipeline & Science
Pipeline
FBX-101 for Krabbe Disease
About Gene Therapy
Patients & Caregivers
Careers
News & Insights
News
Events
Insights
Media Kit
Connect
clinical trials
Forge Biologics Cleared for Clinical Trial of FBX-101, a Krabbe Disease Treatment
FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
United Leukodystrophy Foundation
RESKUE Trial for Patients with Krabbe Disease
FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
I agree to the Cookie Notice and Privacy Policy
I agree
